Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
-
26/01/2025, 11:39
-
ansa.it
0
Scopri altro
- oggi, 09:33
-
repubblica.it
-
0
- 26/03/2025, 11:39
-
ansa.it
-
0
- 26/03/2025, 11:39
-
ansa.it
-
0
- 26/03/2025, 11:39
-
ansa.it
-
0
- 26/03/2025, 11:39
-
ansa.it
-
0
- 26/03/2025, 11:33
-
ansa.it
-
0
- 26/03/2025, 11:33
-
ansa.it
-
0
- 26/03/2025, 11:30
-
ansa.it
-
0
Nessun commento